STX8
Basic information
Region (hg38): 17:9250471-9576591
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STX8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 1 | 1 |
Variants in STX8
This is a list of pathogenic ClinVar variants found in the STX8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-9250601-C-G | not specified | Uncertain significance (Nov 22, 2022) | ||
17-9250630-A-G | not specified | Uncertain significance (Mar 06, 2023) | ||
17-9378599-T-C | not specified | Uncertain significance (Jan 23, 2023) | ||
17-9491909-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
17-9505039-T-G | not specified | Uncertain significance (May 30, 2024) | ||
17-9505052-T-G | Malignant tumor of prostate | Uncertain significance (-) | ||
17-9505058-T-A | not specified | Uncertain significance (Apr 07, 2023) | ||
17-9505091-G-A | not specified | Uncertain significance (May 27, 2022) | ||
17-9505113-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
17-9557525-T-C | not specified | Uncertain significance (Apr 12, 2022) | ||
17-9568370-C-T | Uncertain significance (Aug 15, 2023) | |||
17-9568379-C-T | not specified | Likely benign (Aug 21, 2023) | ||
17-9568388-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
17-9568399-T-C | not specified | Uncertain significance (Sep 26, 2023) | ||
17-9568408-C-T | not specified | Uncertain significance (Jun 10, 2022) | ||
17-9568435-T-C | not specified | Uncertain significance (Mar 02, 2023) | ||
17-9575802-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
17-9575803-T-C | Benign (Mar 29, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STX8 | protein_coding | protein_coding | ENST00000306357 | 8 | 326121 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.32e-8 | 0.362 | 125708 | 0 | 39 | 125747 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.544 | 148 | 131 | 1.13 | 0.00000692 | 1542 |
Missense in Polyphen | 53 | 47.128 | 1.1246 | 578 | ||
Synonymous | 0.896 | 38 | 45.7 | 0.831 | 0.00000247 | 436 |
Loss of Function | 0.772 | 14 | 17.5 | 0.801 | 0.00000108 | 171 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000382 | 0.000381 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000265 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Vesicle trafficking protein that functions in the early secretory pathway, possibly by mediating retrograde transport from cis-Golgi membranes to the ER.;
- Pathway
- SNARE interactions in vesicular transport - Homo sapiens (human);Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics
(Consensus)
Recessive Scores
- pRec
- 0.201
Intolerance Scores
- loftool
- 0.374
- rvis_EVS
- 0.64
- rvis_percentile_EVS
- 83.78
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.502
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stx8
- Phenotype
- skeleton phenotype; normal phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- intracellular protein transport;vesicle fusion;endosome to lysosome transport;early endosome to late endosome transport;vesicle docking;cellular response to interferon-gamma;regulation of protein localization to plasma membrane
- Cellular component
- lysosomal membrane;endosome;early endosome;late endosome;endoplasmic reticulum;trans-Golgi network;cytosol;integral component of plasma membrane;endomembrane system;integral component of membrane;SNARE complex;late endosome membrane;vesicle;phagocytic vesicle;perinuclear region of cytoplasm;recycling endosome
- Molecular function
- SNARE binding;SNAP receptor activity;protein binding;chloride channel inhibitor activity;syntaxin binding;ubiquitin protein ligase binding